Statistics

Total Visits

Views
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer. 402

Total Visits Per Month

March 2024 April 2024 May 2024 June 2024 July 2024 August 2024 September 2024
The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer. 0 6 1 3 0 5 1

File Visits

Views
sanchez-ccr-thef.pdf 332

Top country views

Views
United States 279
France 25
Spain 20
Ireland 18
Sweden 16
Germany 12
China 7
Brazil 5
United Kingdom 5
Italy 4

Top cities views

Views
Ashburn 84
Fairfield 47
Dublin 18
Mountain View 18
San Ramon 17
Cambridge 13
Barcelona 9
Boardman 8
Sunnyvale 7
Seattle 6

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking